Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle
Clinical trial NCT01071200 · TERMINATED
Trial details
- NCT number
- NCT01071200
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2009-04-01
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.